DESANTIS, JENNY
 Distribuzione geografica
Continente #
NA - Nord America 1.492
AS - Asia 1.087
EU - Europa 811
SA - Sud America 147
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 27
OC - Oceania 2
Totale 3.699
Nazione #
US - Stati Uniti d'America 1.419
SG - Singapore 407
IT - Italia 250
VN - Vietnam 193
CN - Cina 158
HK - Hong Kong 137
RU - Federazione Russa 119
IE - Irlanda 113
BR - Brasile 112
DE - Germania 62
FR - Francia 48
BD - Bangladesh 47
SE - Svezia 38
CA - Canada 37
FI - Finlandia 37
IN - India 29
KR - Corea 27
BE - Belgio 26
GB - Regno Unito 24
NL - Olanda 16
PL - Polonia 16
JP - Giappone 14
IQ - Iraq 13
AR - Argentina 12
TR - Turchia 11
AT - Austria 10
ES - Italia 10
ID - Indonesia 9
MX - Messico 9
UA - Ucraina 8
PK - Pakistan 7
ZA - Sudafrica 7
EC - Ecuador 6
LT - Lituania 6
SA - Arabia Saudita 6
CR - Costa Rica 5
JM - Giamaica 5
UZ - Uzbekistan 5
VE - Venezuela 5
CH - Svizzera 4
KE - Kenya 4
RO - Romania 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
CL - Cile 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
NP - Nepal 3
PR - Porto Rico 3
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
PH - Filippine 2
PT - Portogallo 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CV - Capo Verde 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MC - Monaco 1
MU - Mauritius 1
MZ - Mozambico 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TW - Taiwan 1
Totale 3.568
Città #
Singapore 297
Chandler 186
San Jose 162
Ashburn 140
Hong Kong 130
Dublin 113
Dong Ket 100
Perugia 91
Santa Clara 64
Beijing 52
Boardman 50
Council Bluffs 50
Moscow 43
Munich 39
San Mateo 39
Los Angeles 35
The Dalles 32
Ho Chi Minh City 30
Lauterbourg 28
New York 27
Brussels 26
Seoul 26
Altamura 23
Hanoi 22
Princeton 22
Lawrence 21
Medford 21
Helsinki 18
Dallas 15
Denver 13
Rome 13
Montreal 12
Piscataway 12
Orem 11
Wilmington 11
Atlanta 10
Tokyo 10
Turku 10
West Jordan 10
Andover 9
Buffalo 9
Chicago 9
Milan 9
Phoenix 9
Fremont 8
San Francisco 8
Warsaw 8
Da Nang 7
São Paulo 7
Toronto 7
Washington 7
Charlotte 6
Hefei 6
Mumbai 6
Saint Petersburg 6
Stockholm 6
Ankara 5
Chennai 5
Florence 5
Newark 5
Norwalk 5
Nuremberg 5
Portogruaro 5
Calgary 4
Des Moines 4
Dhaka 4
Houston 4
Isorella 4
Jakarta 4
Johannesburg 4
Lappeenranta 4
Mexico City 4
Porto Alegre 4
Poznan 4
Redwood City 4
Rio de Janeiro 4
Salvador 4
Secaucus 4
Shanghai 4
Spoleto 4
Tashkent 4
Vienna 4
Zhengzhou 4
Abidjan 3
Addis Ababa 3
Amsterdam 3
Athens 3
Baku 3
Boston 3
Brasília 3
Brooklyn 3
City of London 3
Columbus 3
Curitiba 3
Erbil 3
Fairfield 3
Honolulu 3
Hải Dương 3
Jeddah 3
Kingston 3
Totale 2.307
Nome #
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 344
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 153
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 151
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 145
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity 144
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 142
PROTACs bearing piperazine-containing linkers: what effect on their protonation state? 136
Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications 132
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 127
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 123
VHL-Modified PROteolysis TArgeting Chimeras (PROTACs) as a Strategy to Evade Metabolic Degradation in In Vitro Applications 121
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 120
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 118
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 118
Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs 114
Indomethacin-based PROTACs as pan-coronavirus antiviral agents 114
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design 111
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 111
CROMATIC: Cross-Relationship Map of Cavities from Coronaviruses 109
Automatic Identification of Lansoprazole Degradants under Stress Conditions by LC-HRMS with MassChemSite and WebChembase 107
Effects of MTX-23, a novel PROTAC of androgen receptor splice variant-7 and androgen receptor, on CRPC resistant to second-line antiandrogen therapy 102
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 97
MassChemSite for In-Depth Forced Degradation Analysis of PARP Inhibitors Olaparib, Rucaparib, and Niraparib 92
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 86
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-protein Interaction as a Target for Next-generation Anti-influenza Therapeutics. 83
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis 81
An overview on small molecules acting as broad-spectrum agents for yellow fever infection 80
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 72
Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder. 69
Proteolysis targeting chimeras in antiviral research 53
Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV 47
LC‐MS and High‐Throughput Data Processing Solutions for Lipid Metabolic Tracing Using Bioorthogonal Click Chemistry 34
Novel SARS-CoV-2 allosteric inhibitors that destabilize the Main Protease Mpro dimer 25
Rational optimization of D3R/GSK-3β dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studies 19
Discovery of a tetrahydrobenzothiophen-2-yl-pyrazolo[1,5-a]pyrimidine-3-carboxamide-based PROTAC as degrader of SARS-CoV-2 main protease 19
Totale 3.699
Categoria #
all - tutte 16.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022142 0 0 0 9 3 1 3 45 20 5 34 22
2022/2023479 22 100 16 49 36 50 0 27 158 2 16 3
2023/2024271 11 41 10 9 5 7 61 3 14 27 39 44
2024/2025662 10 73 23 42 70 50 88 28 118 44 79 37
2025/20261.416 85 107 65 171 199 118 244 77 152 97 50 51
2026/2027388 38 49 97 204 0 0 0 0 0 0 0 0
Totale 3.699